A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus ® in Healthy Male Volunteers
Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus Interventions: Drug: HEC-Glargine; Drug: US-Lantus Sponsors: Lannett Company, Inc.; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials